Loading clinical trials...
Loading clinical trials...
Cerebral palsy (CP) is a prevalent pediatric neurological disorder hindering movement and posture development due to non-progressive disruptions in brain development. Motor disorders along with dysfunctions in sensations, perception, cognition, communication, behavior and secondary musculoskeletal problems are also present in children with CP. Cuevas Medek Exercises (CME) is an innovative, intensive and dynamic therapy approach for management of movement disorders. It evoke automatic postural responses in children with motor delay problems by application of distal support, triggering stronger gravity induced reactions to enhanced motor output by compelling both mind and body responses. It incorporates antigravity posture, ROM, weight-bearing, and stretching into functional exercises; for improved agility, flexibility, balance and coordination.
OBJECTIVES: The objectives of this study are: 1. To determine the additional effect of Cuevas Medek Exercises with conventional exercises on gross motor proficiency in children with spastic diplegic cerebral palsy. 2. To determine the additional effect of Cuevas Medek Exercises with conventional exercises on quality of life of caregiver and children with spastic diplegic cerebral palsy. HYPOTHESIS: Alternate Hypothesis: 1. There is a statistically significant effect of Cuevas Medek Exercises in conjunction with conventional physical therapy as compared to conventional physical therapy alone on gross motor proficiency in children with spastic diplegic cerebral palsy. (p\<0.05) 2. There is a statistically significant effect of Cuevas Medek Exercises in conjunction with conventional physical therapy as compared to conventional physical therapy alone on quality of life in children with spastic diplegic cerebral palsy. (p\<0.05) Null Hypothesis: 1. There is a statistically no significant effect of Cuevas Medek Exercises in conjunction with conventional physical therapy as compared to conventional physical therapy alone on gross motor proficiency in children with spastic diplegic cerebral palsy. (p\>0.05) 2. There is a statistically no significant effect of Cuevas Medek Exercises in conjunction with conventional physical therapy as compared to conventional physical therapy alone on quality of life in children with spastic diplegic cerebral palsy. (p\>0.05) Research Design: Experimental study. Randomized Control Trial Clinical setting: Fauji Foundation Hospital Study duration 1 year following synopsis approval.(Feb 2024- Jan 2025) Selection Criteria: Inclusion Criteria * diagnosed spastic diplegic cerebral palsy children * age group 6-12 years old * both male and female * GMFCS II \& III * parents of spastic diplegic CP child Exclusion Criteria * diagnosed cognitive impairment * diagnosed hearing impairment and visual impairment * children with planned surgical procedures during study period Sampling technique: convenicence sampling Outcome Measures: 1. Gross motor function measure 2. CP QOL - CHILD Data analysis techniques: Data will be analyzed using SPSS version 20.0.0. Significance of the study: * Till date no study has yet evaluated the effect of Cuevas Medek Exrcises on gross motor proficiency and quality of life in children with spastic diplegic cerebral palsy. Therefore, advancement in the scientific knowledge can be achieved. * Caregivers of cerebral palsy suffer from a substantial psychosocial burden. Therefore, to determine whether CME Therapy effects functional dependency and quality of life of both patient and caregivers. * This study will contribute to future research directions and encouraging further exploration of CME Therapy as a promising intervention for spastic diplegic cerebral palsy.
Age
6 - 12 years
Sex
ALL
Healthy Volunteers
No
Foundation University College of Physical Thrapy
Islamabad, Pakistan
Start Date
June 10, 2024
Primary Completion Date
December 1, 2024
Completion Date
December 20, 2024
Last Updated
May 13, 2025
56
ACTUAL participants
Control Group
PROCEDURE
Experimental Group
PROCEDURE
Lead Sponsor
Foundation University Islamabad
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07442682